Detalhe da pesquisa
1.
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial.
Mol Cancer
; 22(1): 129, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37563568
2.
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.
Br J Cancer
; 129(8): 1327-1338, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620410
3.
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
J Neurooncol
; 163(2): 327-338, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237151
4.
Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.
Int J Mol Sci
; 24(21)2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958662
5.
3D-Engineered Scaffolds to Study Microtubes and Localization of Epidermal Growth Factor Receptor in Patient-Derived Glioma Cells.
Small
; 18(49): e2204485, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207287
6.
Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.
Int J Cancer
; 137(7): 1630-42, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802036
7.
Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy.
Radiology
; 275(3): 746-54, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25686366
8.
ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
J Transl Med
; 13: 74, 2015 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886061
9.
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.
Acta Neuropathol
; 129(4): 597-607, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724300
10.
An autologous ex vivo model for exploring patient-specific responses to viro-immunotherapy in glioblastoma.
Cell Rep Methods
; 4(3): 100716, 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430913
11.
The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles.
Mol Ther Oncol
; 32(2): 200804, 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38694569
12.
Therapeutic concentrations of anti-epileptic drugs do not inhibit the activity of the oncolytic adenovirus Delta24-RGD in malignant glioma.
J Gene Med
; 15(3-4): 134-41, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23606319
13.
IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo.
Ann Neurol
; 69(3): 455-63, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21446021
14.
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors.
Cancers (Basel)
; 14(3)2022 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158868
15.
Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma.
Cancers (Basel)
; 14(15)2022 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954371
16.
Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in glioblastoma.
Front Oncol
; 12: 1012236, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36408180
17.
Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures.
ACS Omega
; 7(4): 3568-3578, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35128264
18.
Nonhuman Primate Adenoviruses of the Human Adenovirus B Species Are Potent and Broadly Acting Oncolytic Vector Candidates.
Hum Gene Ther
; 33(5-6): 275-289, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34861769
19.
Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers.
Neuro Oncol
; 24(12): 2133-2145, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639831
20.
Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.
Clin Cancer Res
; 28(8): 1572-1585, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176144